Your browser doesn't support javascript.
loading
Anti-oxidant and neuro-modulatory effects of bioactive Byttneria pilosa leaf extract in swiss albino mice using behavioral models.
Jyoti, Mifta Ahmed; Shah, Md Shahin; Uddin, Mohammad Najim; Hossain, Mohammed Kamrul; Han, Aixia; Geng, Peiwu; Islam, Mohammad Nazmul; Mamun, Abdullah Al.
Afiliação
  • Jyoti MA; Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh.
  • Shah MS; Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh.
  • Uddin MN; Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh.
  • Hossain MK; Department of Pharmacy, Faculty of Life and Earth Science, Jagannath University, Dhaka,Bangladesh.
  • Han A; Department of Pharmacy, Faculty of Biological Sciences, University of Chittagong, Chittagong, Bangladesh.
  • Geng P; Central Laboratory of The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, Zhejiang, China.
  • Islam MN; Central Laboratory of The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, Zhejiang, China.
  • Mamun AA; Department of Pharmacy, International Islamic University Chittagong, Chittagong, Bangladesh.
Front Chem ; 12: 1341308, 2024.
Article em En | MEDLINE | ID: mdl-38389724
ABSTRACT
Byttneria pilosa, a flowering plant from the Malvaceae family traditionally used to treat ailments such as boils and scabies, is here investigated for its potential health benefits. The study focused on evaluating its antioxidant and antidiabetic properties in vitro, as well as the in vivo anxiolytic and antidepressant activities of the methanol extract of B. pilosa leaf (MEBP). The study employed various assays to evaluate antioxidant activity, including 2, 2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, reducing power capacity, and quantification of the total phenolic and flavonoid contents of MEBP. Additionally, anxiolytic and antidepressant activities were evaluated through four tests elevated plus-maze test (EPMT), light-dark box test (LDBT), forced swimming test (FST), and tail suspension test (TST). Antidiabetic effect was determined using α-amylase inhibition assay. Docking analysis was performed using BIOVIA and Schrödinger Maestro (v11.1), and the absorption, distribution, metabolism, and excretion/toxicity (ADME/T) properties of bioactive substances were investigated using a web-based technique. MEBP exhibited moderate antioxidant activity in DPPH radical scavenging and reducing power capacity assays, with a dose-dependent response. The total phenolic and flavonoid contents measured were 70 ± 1.53 mg and 22.33 ± 1.20 mg, respectively. MEBP demonstrated significant effects in α-amylase inhibition comparable to acarbose. In behavioral tests, MEBP dose-dependently altered time spent in open arms/light box and closed arms/dark box, indicating anxiolytic effects. Moreover, MEBP significantly reduced immobility duration in FST and TST, suggesting antidepressant properties. Molecular docking analysis revealed favorable interactions between beta-sitosterol and specific targets, suggesting the potential mediation of anxiolytic and antidiabetic effects. Overall, MEBP exhibits notable anxiolytic and antidepressant properties, along with moderate antioxidant and antidiabetic activities.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Idioma: En Revista: Front Chem Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Idioma: En Revista: Front Chem Ano de publicação: 2024 Tipo de documento: Article